Testing experimental therapies in a Guinea pig model for hemorrhagic fever

Gary Wong, Yuhai Bi, Gary Kobinger, George F. Gao, Xiangguo Qiu

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Hemorrhagic fever viruses are among the deadliest pathogens known to humans, and often, licensed medical countermeasures are unavailable to prevent or treat infections. Guinea pigs are a commonly used animal for the preclinical development of any experimental candidates, typically to confirm data generated in mice and as a way to validate and support further testing in nonhuman primates. In this chapter, we use Sudan virus (SUDV), a lethal filovirus closely related to Ebola virus, as an example of the steps required for generating a guinea pig-adapted isolate that is used to test a monoclonal antibody-based therapy against viral hemorrhagic fevers.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages269-278
Number of pages10
DOIs
StatePublished - 2018
Externally publishedYes

Publication series

NameMethods in Molecular Biology
Volume1604
ISSN (Print)1064-3745

Keywords

  • Guinea pigs
  • Hemorrhagic fever
  • Monoclonal antibodies
  • Serial passaging
  • Sudan virus

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Fingerprint

Dive into the research topics of 'Testing experimental therapies in a Guinea pig model for hemorrhagic fever'. Together they form a unique fingerprint.

Cite this